Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Other Non-Current Liabilities (2020 - 2025)

Biofrontera (BFRI) has 6 years of Other Non-Current Liabilities data on record, last reported at $833000.0 in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities fell 47.97% year-over-year to $833000.0; the TTM value through Sep 2025 reached $833000.0, down 47.97%, while the annual FY2024 figure was $1.2 million, 70.31% down from the prior year.
  • Other Non-Current Liabilities reached $833000.0 in Q3 2025 per BFRI's latest filing, up from $14000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $12.9 million in Q4 2021 and bottomed at $14000.0 in Q2 2025.
  • Average Other Non-Current Liabilities over 5 years is $4.1 million, with a median of $2.4 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Liabilities: surged 20632.26% in 2021, then crashed 98.48% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $12.9 million in 2021, then crashed by 81.33% to $2.4 million in 2022, then surged by 75.42% to $4.2 million in 2023, then crashed by 70.31% to $1.2 million in 2024, then plummeted by 33.36% to $833000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $833000.0 in Q3 2025, $14000.0 in Q2 2025, and $702000.0 in Q1 2025.